U.K. Life Sciences Minister Faces Hurdles To Plans To Speed Drug Access
This article was originally published in The Pink Sheet Daily
Executive Summary
British life sciences minister George Freeman has launched ambitious plans to speed access to drugs by cutting drug development times by a third – but his plans face many hurdles.
You may also be interested in...
Adapting HTA To A Value-Based Approach: A Conversation With ABPI's Stephen Whitehead
The Association of the British Pharmaceutical Industry's chief executive says a focus on drug value rather than cost, and an adaptive approach to health technology assessment are approaches that would encourage pharma innovation.
European Notebook: Sanofi Exiting Toulouse; Job Cuts At Pierre Fabre; Generics Suspended In Four States
The newly formed European Commission sets out plans to improve industrial growth and international trade while leading French pharma companies Sanofi and Pierre Fabre announce plans to trim their R&D workforces. Asian companies in contrast are seeking growth opportunities in Europe, including India’s Cipla and Thailand’s CP Group.
European Notebook: Sanofi Exiting Toulouse; Job Cuts At Pierre Fabre; Generics Suspended In Four States
The newly formed European Commission sets out plans to improve industrial growth and international trade while leading French pharma companies Sanofi and Pierre Fabre announce plans to trim their R&D workforces. Asian companies in contrast are seeking growth opportunities in Europe, including India’s Cipla and Thailand’s CP Group.